JPRN-jRCT1090220061已完成Unknown
Measurement of WT1-mRNA as a Prognostic Factor in Acute Myeloid Leukemia - Measurement of WT1-mRNA in Acute Myeloid Leukemia Patients
Shuichi Miyawaki;Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital.0 个研究点目标入组 100 人开始时间: 2011年6月2日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 17age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •Untreated, de novo AML patients, who are positi
- •ve for WT1-mRNA at diagnosis and without previous history of myelodysplastic syndrome.
排除标准
- •AML cases who did not achieve complete remission after one-/two- course of remission-induction therapy.
研究者
相似试验
已完成
Unknown
Prognostic Potential of Detection of WT1-mRNA in Acute Myeloid LeukemiaAcute myeloid leukemia (AML)JPRN-jRCT1090220039Shuichi Miyawaki;Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital.50
招募中
不适用
Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.lower-risk myelodysplastic syndromesJPRN-UMIN000017862Jichi Medical University100
已完成
不适用
WT1 expression as an early predictor for molecular relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy plus all-trans retinoic acidDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0002079The Catholic University of Korea, Seoul St. Mary's Hospital117
尚未招募
1 期
Phase I study of Wilms' tumor gene WT1 peptide vaccination combined with gemcitabine for patients with advanced non-small-cell lung canceradvanced or recurrent non-small-cell lung cancerJPRN-UMIN000005226School of Medicine, Keio University10
已完成
1 期
Phase I study of Wilms' tumor gene WT1 peptide pulsed dendritic cell vaccination combined with docetaxel for patients with advanced or recurrent esophageal cancerAdvanced or recurrent esophageal cancerJPRN-UMIN000006704School of Medicine, Keio University10